Adipocyte-derived ANGPTL4 was beneficial to breast cancer angiogenesis and progression in obesity and was a potential therapeutic target for obese breast cancer patients. Here, ANGPTL4 is linked to obesity due to melanocortin 4 receptor deficiency.